Iq Eq Fund Management (Ireland) LTD Veracyte, Inc. Transaction History
Iq Eq Fund Management (Ireland) LTD
- $833 Million
- Q1 2025
A detailed history of Iq Eq Fund Management (Ireland) LTD transactions in Veracyte, Inc. stock. As of the latest transaction made, Iq Eq Fund Management (Ireland) LTD holds 30,604 shares of VCYT stock, worth $807,639. This represents 0.11% of its overall portfolio holdings.
Number of Shares
30,604
Previous 18,156
68.56%
Holding current value
$807,639
Previous $718,000
26.32%
% of portfolio
0.11%
Previous 0.09%
Shares
3 transactions
Others Institutions Holding VCYT
# of Institutions
306Shares Held
79.1MCall Options Held
15.5KPut Options Held
16.7K-
Vanguard Group Inc Valley Forge, PA8.26MShares$218 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$206 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.24MShares$138 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl3.94MShares$104 Million1.26% of portfolio
-
Wellington Management Group LLP Boston, MA3.85MShares$102 Million0.02% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $1.89B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...